HCV eradication does not protect from fibrosis progression in patients with fibrosing cholestatic hepatitis after liver transplantation
• Fibrosing cholestatic hepatitis is a rare and very severe form of HCV recurrence after liver transplantation. • Prognosis of HCV recurrence after liver transplantation has been dramatically modified because of direct antivirals. • Histological outcome of 17 patients has been studied. • Fibrosis st...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Coilly, Audrey [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2022 |
|---|
| Übergeordnetes Werk: |
Enthalten in: A 4.5 - Holmes, Jason ELSEVIER, 2018, Amsterdam |
|---|---|
| Übergeordnetes Werk: |
volume:46 ; year:2022 ; number:9 ; pages:0 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.clinre.2022.102024 |
|---|
| Katalog-ID: |
ELV059401818 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV059401818 | ||
| 003 | DE-627 | ||
| 005 | 20230625013247.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 221219s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.clinre.2022.102024 |2 doi | |
| 028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001952.pica |
| 035 | |a (DE-627)ELV059401818 | ||
| 035 | |a (ELSEVIER)S2210-7401(22)00158-9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 530 |q VZ |
| 084 | |a 33.05 |2 bkl | ||
| 084 | |a 33.07 |2 bkl | ||
| 084 | |a 33.40 |2 bkl | ||
| 100 | 1 | |a Coilly, Audrey |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a HCV eradication does not protect from fibrosis progression in patients with fibrosing cholestatic hepatitis after liver transplantation |
| 264 | 1 | |c 2022 | |
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a • Fibrosing cholestatic hepatitis is a rare and very severe form of HCV recurrence after liver transplantation. • Prognosis of HCV recurrence after liver transplantation has been dramatically modified because of direct antivirals. • Histological outcome of 17 patients has been studied. • Fibrosis stage worsened in the majority of patients with fibrosing cholestatic hepatitis despite HCV cure. | ||
| 700 | 1 | |a Sebagh, Mylène |4 oth | |
| 700 | 1 | |a Fougerou-Leurent, Claire |4 oth | |
| 700 | 1 | |a Pageaux, Georges-Philippe |4 oth | |
| 700 | 1 | |a Leroy, Vincent |4 oth | |
| 700 | 1 | |a Radenne, Sylvie |4 oth | |
| 700 | 1 | |a Silvain, Christine |4 oth | |
| 700 | 1 | |a Lebray, Pascal |4 oth | |
| 700 | 1 | |a Houssel-Debry, Pauline |4 oth | |
| 700 | 1 | |a Cagnot, Carole |4 oth | |
| 700 | 1 | |a Rossignol, Emilie |4 oth | |
| 700 | 1 | |a Danjou, Hélène |4 oth | |
| 700 | 1 | |a Veislinger, Aurélie |4 oth | |
| 700 | 1 | |a Samuel, Didier |4 oth | |
| 700 | 1 | |a Duclos-Vallée, Jean-Charles |4 oth | |
| 700 | 1 | |a Dumortier, Jérôme |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Masson |a Holmes, Jason ELSEVIER |t A 4.5 |d 2018 |g Amsterdam |w (DE-627)ELV000519456 |
| 773 | 1 | 8 | |g volume:46 |g year:2022 |g number:9 |g pages:0 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.clinre.2022.102024 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 936 | b | k | |a 33.05 |j Experimentalphysik |q VZ |
| 936 | b | k | |a 33.07 |j Spektroskopie |q VZ |
| 936 | b | k | |a 33.40 |j Kernphysik |q VZ |
| 951 | |a AR | ||
| 952 | |d 46 |j 2022 |e 9 |h 0 | ||
| author_variant |
a c ac |
|---|---|
| matchkey_str |
coillyaudreysebaghmylnefougerouleurentcl:2022----:ceaiainosopoetrmirssrgesoiptetwtfboighlsaih |
| hierarchy_sort_str |
2022 |
| bklnumber |
33.05 33.07 33.40 |
| publishDate |
2022 |
| allfields |
10.1016/j.clinre.2022.102024 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001952.pica (DE-627)ELV059401818 (ELSEVIER)S2210-7401(22)00158-9 DE-627 ger DE-627 rakwb eng 530 VZ 33.05 bkl 33.07 bkl 33.40 bkl Coilly, Audrey verfasserin aut HCV eradication does not protect from fibrosis progression in patients with fibrosing cholestatic hepatitis after liver transplantation 2022 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Fibrosing cholestatic hepatitis is a rare and very severe form of HCV recurrence after liver transplantation. • Prognosis of HCV recurrence after liver transplantation has been dramatically modified because of direct antivirals. • Histological outcome of 17 patients has been studied. • Fibrosis stage worsened in the majority of patients with fibrosing cholestatic hepatitis despite HCV cure. Sebagh, Mylène oth Fougerou-Leurent, Claire oth Pageaux, Georges-Philippe oth Leroy, Vincent oth Radenne, Sylvie oth Silvain, Christine oth Lebray, Pascal oth Houssel-Debry, Pauline oth Cagnot, Carole oth Rossignol, Emilie oth Danjou, Hélène oth Veislinger, Aurélie oth Samuel, Didier oth Duclos-Vallée, Jean-Charles oth Dumortier, Jérôme oth Enthalten in Elsevier Masson Holmes, Jason ELSEVIER A 4.5 2018 Amsterdam (DE-627)ELV000519456 volume:46 year:2022 number:9 pages:0 https://doi.org/10.1016/j.clinre.2022.102024 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 33.05 Experimentalphysik VZ 33.07 Spektroskopie VZ 33.40 Kernphysik VZ AR 46 2022 9 0 |
| spelling |
10.1016/j.clinre.2022.102024 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001952.pica (DE-627)ELV059401818 (ELSEVIER)S2210-7401(22)00158-9 DE-627 ger DE-627 rakwb eng 530 VZ 33.05 bkl 33.07 bkl 33.40 bkl Coilly, Audrey verfasserin aut HCV eradication does not protect from fibrosis progression in patients with fibrosing cholestatic hepatitis after liver transplantation 2022 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Fibrosing cholestatic hepatitis is a rare and very severe form of HCV recurrence after liver transplantation. • Prognosis of HCV recurrence after liver transplantation has been dramatically modified because of direct antivirals. • Histological outcome of 17 patients has been studied. • Fibrosis stage worsened in the majority of patients with fibrosing cholestatic hepatitis despite HCV cure. Sebagh, Mylène oth Fougerou-Leurent, Claire oth Pageaux, Georges-Philippe oth Leroy, Vincent oth Radenne, Sylvie oth Silvain, Christine oth Lebray, Pascal oth Houssel-Debry, Pauline oth Cagnot, Carole oth Rossignol, Emilie oth Danjou, Hélène oth Veislinger, Aurélie oth Samuel, Didier oth Duclos-Vallée, Jean-Charles oth Dumortier, Jérôme oth Enthalten in Elsevier Masson Holmes, Jason ELSEVIER A 4.5 2018 Amsterdam (DE-627)ELV000519456 volume:46 year:2022 number:9 pages:0 https://doi.org/10.1016/j.clinre.2022.102024 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 33.05 Experimentalphysik VZ 33.07 Spektroskopie VZ 33.40 Kernphysik VZ AR 46 2022 9 0 |
| allfields_unstemmed |
10.1016/j.clinre.2022.102024 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001952.pica (DE-627)ELV059401818 (ELSEVIER)S2210-7401(22)00158-9 DE-627 ger DE-627 rakwb eng 530 VZ 33.05 bkl 33.07 bkl 33.40 bkl Coilly, Audrey verfasserin aut HCV eradication does not protect from fibrosis progression in patients with fibrosing cholestatic hepatitis after liver transplantation 2022 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Fibrosing cholestatic hepatitis is a rare and very severe form of HCV recurrence after liver transplantation. • Prognosis of HCV recurrence after liver transplantation has been dramatically modified because of direct antivirals. • Histological outcome of 17 patients has been studied. • Fibrosis stage worsened in the majority of patients with fibrosing cholestatic hepatitis despite HCV cure. Sebagh, Mylène oth Fougerou-Leurent, Claire oth Pageaux, Georges-Philippe oth Leroy, Vincent oth Radenne, Sylvie oth Silvain, Christine oth Lebray, Pascal oth Houssel-Debry, Pauline oth Cagnot, Carole oth Rossignol, Emilie oth Danjou, Hélène oth Veislinger, Aurélie oth Samuel, Didier oth Duclos-Vallée, Jean-Charles oth Dumortier, Jérôme oth Enthalten in Elsevier Masson Holmes, Jason ELSEVIER A 4.5 2018 Amsterdam (DE-627)ELV000519456 volume:46 year:2022 number:9 pages:0 https://doi.org/10.1016/j.clinre.2022.102024 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 33.05 Experimentalphysik VZ 33.07 Spektroskopie VZ 33.40 Kernphysik VZ AR 46 2022 9 0 |
| allfieldsGer |
10.1016/j.clinre.2022.102024 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001952.pica (DE-627)ELV059401818 (ELSEVIER)S2210-7401(22)00158-9 DE-627 ger DE-627 rakwb eng 530 VZ 33.05 bkl 33.07 bkl 33.40 bkl Coilly, Audrey verfasserin aut HCV eradication does not protect from fibrosis progression in patients with fibrosing cholestatic hepatitis after liver transplantation 2022 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Fibrosing cholestatic hepatitis is a rare and very severe form of HCV recurrence after liver transplantation. • Prognosis of HCV recurrence after liver transplantation has been dramatically modified because of direct antivirals. • Histological outcome of 17 patients has been studied. • Fibrosis stage worsened in the majority of patients with fibrosing cholestatic hepatitis despite HCV cure. Sebagh, Mylène oth Fougerou-Leurent, Claire oth Pageaux, Georges-Philippe oth Leroy, Vincent oth Radenne, Sylvie oth Silvain, Christine oth Lebray, Pascal oth Houssel-Debry, Pauline oth Cagnot, Carole oth Rossignol, Emilie oth Danjou, Hélène oth Veislinger, Aurélie oth Samuel, Didier oth Duclos-Vallée, Jean-Charles oth Dumortier, Jérôme oth Enthalten in Elsevier Masson Holmes, Jason ELSEVIER A 4.5 2018 Amsterdam (DE-627)ELV000519456 volume:46 year:2022 number:9 pages:0 https://doi.org/10.1016/j.clinre.2022.102024 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 33.05 Experimentalphysik VZ 33.07 Spektroskopie VZ 33.40 Kernphysik VZ AR 46 2022 9 0 |
| allfieldsSound |
10.1016/j.clinre.2022.102024 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001952.pica (DE-627)ELV059401818 (ELSEVIER)S2210-7401(22)00158-9 DE-627 ger DE-627 rakwb eng 530 VZ 33.05 bkl 33.07 bkl 33.40 bkl Coilly, Audrey verfasserin aut HCV eradication does not protect from fibrosis progression in patients with fibrosing cholestatic hepatitis after liver transplantation 2022 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Fibrosing cholestatic hepatitis is a rare and very severe form of HCV recurrence after liver transplantation. • Prognosis of HCV recurrence after liver transplantation has been dramatically modified because of direct antivirals. • Histological outcome of 17 patients has been studied. • Fibrosis stage worsened in the majority of patients with fibrosing cholestatic hepatitis despite HCV cure. Sebagh, Mylène oth Fougerou-Leurent, Claire oth Pageaux, Georges-Philippe oth Leroy, Vincent oth Radenne, Sylvie oth Silvain, Christine oth Lebray, Pascal oth Houssel-Debry, Pauline oth Cagnot, Carole oth Rossignol, Emilie oth Danjou, Hélène oth Veislinger, Aurélie oth Samuel, Didier oth Duclos-Vallée, Jean-Charles oth Dumortier, Jérôme oth Enthalten in Elsevier Masson Holmes, Jason ELSEVIER A 4.5 2018 Amsterdam (DE-627)ELV000519456 volume:46 year:2022 number:9 pages:0 https://doi.org/10.1016/j.clinre.2022.102024 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 33.05 Experimentalphysik VZ 33.07 Spektroskopie VZ 33.40 Kernphysik VZ AR 46 2022 9 0 |
| language |
English |
| source |
Enthalten in A 4.5 Amsterdam volume:46 year:2022 number:9 pages:0 |
| sourceStr |
Enthalten in A 4.5 Amsterdam volume:46 year:2022 number:9 pages:0 |
| format_phy_str_mv |
Article |
| bklname |
Experimentalphysik Spektroskopie Kernphysik |
| institution |
findex.gbv.de |
| dewey-raw |
530 |
| isfreeaccess_bool |
false |
| container_title |
A 4.5 |
| authorswithroles_txt_mv |
Coilly, Audrey @@aut@@ Sebagh, Mylène @@oth@@ Fougerou-Leurent, Claire @@oth@@ Pageaux, Georges-Philippe @@oth@@ Leroy, Vincent @@oth@@ Radenne, Sylvie @@oth@@ Silvain, Christine @@oth@@ Lebray, Pascal @@oth@@ Houssel-Debry, Pauline @@oth@@ Cagnot, Carole @@oth@@ Rossignol, Emilie @@oth@@ Danjou, Hélène @@oth@@ Veislinger, Aurélie @@oth@@ Samuel, Didier @@oth@@ Duclos-Vallée, Jean-Charles @@oth@@ Dumortier, Jérôme @@oth@@ |
| publishDateDaySort_date |
2022-01-01T00:00:00Z |
| hierarchy_top_id |
ELV000519456 |
| dewey-sort |
3530 |
| id |
ELV059401818 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV059401818</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625013247.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">221219s2022 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.clinre.2022.102024</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001952.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV059401818</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S2210-7401(22)00158-9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">530</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">33.05</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">33.07</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">33.40</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Coilly, Audrey</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">HCV eradication does not protect from fibrosis progression in patients with fibrosing cholestatic hepatitis after liver transplantation</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Fibrosing cholestatic hepatitis is a rare and very severe form of HCV recurrence after liver transplantation. • Prognosis of HCV recurrence after liver transplantation has been dramatically modified because of direct antivirals. • Histological outcome of 17 patients has been studied. • Fibrosis stage worsened in the majority of patients with fibrosing cholestatic hepatitis despite HCV cure.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sebagh, Mylène</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fougerou-Leurent, Claire</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pageaux, Georges-Philippe</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Leroy, Vincent</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Radenne, Sylvie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Silvain, Christine</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lebray, Pascal</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Houssel-Debry, Pauline</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cagnot, Carole</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rossignol, Emilie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Danjou, Hélène</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Veislinger, Aurélie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Samuel, Didier</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Duclos-Vallée, Jean-Charles</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dumortier, Jérôme</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Masson</subfield><subfield code="a">Holmes, Jason ELSEVIER</subfield><subfield code="t">A 4.5 </subfield><subfield code="d">2018</subfield><subfield code="g">Amsterdam</subfield><subfield code="w">(DE-627)ELV000519456</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:46</subfield><subfield code="g">year:2022</subfield><subfield code="g">number:9</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.clinre.2022.102024</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">33.05</subfield><subfield code="j">Experimentalphysik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">33.07</subfield><subfield code="j">Spektroskopie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">33.40</subfield><subfield code="j">Kernphysik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">46</subfield><subfield code="j">2022</subfield><subfield code="e">9</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
| author |
Coilly, Audrey |
| spellingShingle |
Coilly, Audrey ddc 530 bkl 33.05 bkl 33.07 bkl 33.40 HCV eradication does not protect from fibrosis progression in patients with fibrosing cholestatic hepatitis after liver transplantation |
| authorStr |
Coilly, Audrey |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV000519456 |
| format |
electronic Article |
| dewey-ones |
530 - Physics |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
530 VZ 33.05 bkl 33.07 bkl 33.40 bkl HCV eradication does not protect from fibrosis progression in patients with fibrosing cholestatic hepatitis after liver transplantation |
| topic |
ddc 530 bkl 33.05 bkl 33.07 bkl 33.40 |
| topic_unstemmed |
ddc 530 bkl 33.05 bkl 33.07 bkl 33.40 |
| topic_browse |
ddc 530 bkl 33.05 bkl 33.07 bkl 33.40 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
m s ms c f l cfl g p p gpp v l vl s r sr c s cs p l pl p h d phd c c cc e r er h d hd a v av d s ds j c d v jcdv j d jd |
| hierarchy_parent_title |
A 4.5 |
| hierarchy_parent_id |
ELV000519456 |
| dewey-tens |
530 - Physics |
| hierarchy_top_title |
A 4.5 |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV000519456 |
| title |
HCV eradication does not protect from fibrosis progression in patients with fibrosing cholestatic hepatitis after liver transplantation |
| ctrlnum |
(DE-627)ELV059401818 (ELSEVIER)S2210-7401(22)00158-9 |
| title_full |
HCV eradication does not protect from fibrosis progression in patients with fibrosing cholestatic hepatitis after liver transplantation |
| author_sort |
Coilly, Audrey |
| journal |
A 4.5 |
| journalStr |
A 4.5 |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
500 - Science |
| recordtype |
marc |
| publishDateSort |
2022 |
| contenttype_str_mv |
zzz |
| container_start_page |
0 |
| author_browse |
Coilly, Audrey |
| container_volume |
46 |
| class |
530 VZ 33.05 bkl 33.07 bkl 33.40 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Coilly, Audrey |
| doi_str_mv |
10.1016/j.clinre.2022.102024 |
| dewey-full |
530 |
| title_sort |
hcv eradication does not protect from fibrosis progression in patients with fibrosing cholestatic hepatitis after liver transplantation |
| title_auth |
HCV eradication does not protect from fibrosis progression in patients with fibrosing cholestatic hepatitis after liver transplantation |
| abstract |
• Fibrosing cholestatic hepatitis is a rare and very severe form of HCV recurrence after liver transplantation. • Prognosis of HCV recurrence after liver transplantation has been dramatically modified because of direct antivirals. • Histological outcome of 17 patients has been studied. • Fibrosis stage worsened in the majority of patients with fibrosing cholestatic hepatitis despite HCV cure. |
| abstractGer |
• Fibrosing cholestatic hepatitis is a rare and very severe form of HCV recurrence after liver transplantation. • Prognosis of HCV recurrence after liver transplantation has been dramatically modified because of direct antivirals. • Histological outcome of 17 patients has been studied. • Fibrosis stage worsened in the majority of patients with fibrosing cholestatic hepatitis despite HCV cure. |
| abstract_unstemmed |
• Fibrosing cholestatic hepatitis is a rare and very severe form of HCV recurrence after liver transplantation. • Prognosis of HCV recurrence after liver transplantation has been dramatically modified because of direct antivirals. • Histological outcome of 17 patients has been studied. • Fibrosis stage worsened in the majority of patients with fibrosing cholestatic hepatitis despite HCV cure. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
| container_issue |
9 |
| title_short |
HCV eradication does not protect from fibrosis progression in patients with fibrosing cholestatic hepatitis after liver transplantation |
| url |
https://doi.org/10.1016/j.clinre.2022.102024 |
| remote_bool |
true |
| author2 |
Sebagh, Mylène Fougerou-Leurent, Claire Pageaux, Georges-Philippe Leroy, Vincent Radenne, Sylvie Silvain, Christine Lebray, Pascal Houssel-Debry, Pauline Cagnot, Carole Rossignol, Emilie Danjou, Hélène Veislinger, Aurélie Samuel, Didier Duclos-Vallée, Jean-Charles Dumortier, Jérôme |
| author2Str |
Sebagh, Mylène Fougerou-Leurent, Claire Pageaux, Georges-Philippe Leroy, Vincent Radenne, Sylvie Silvain, Christine Lebray, Pascal Houssel-Debry, Pauline Cagnot, Carole Rossignol, Emilie Danjou, Hélène Veislinger, Aurélie Samuel, Didier Duclos-Vallée, Jean-Charles Dumortier, Jérôme |
| ppnlink |
ELV000519456 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.clinre.2022.102024 |
| up_date |
2024-07-06T21:53:21.100Z |
| _version_ |
1803868229967282176 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV059401818</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625013247.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">221219s2022 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.clinre.2022.102024</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001952.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV059401818</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S2210-7401(22)00158-9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">530</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">33.05</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">33.07</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">33.40</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Coilly, Audrey</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">HCV eradication does not protect from fibrosis progression in patients with fibrosing cholestatic hepatitis after liver transplantation</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Fibrosing cholestatic hepatitis is a rare and very severe form of HCV recurrence after liver transplantation. • Prognosis of HCV recurrence after liver transplantation has been dramatically modified because of direct antivirals. • Histological outcome of 17 patients has been studied. • Fibrosis stage worsened in the majority of patients with fibrosing cholestatic hepatitis despite HCV cure.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sebagh, Mylène</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fougerou-Leurent, Claire</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pageaux, Georges-Philippe</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Leroy, Vincent</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Radenne, Sylvie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Silvain, Christine</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lebray, Pascal</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Houssel-Debry, Pauline</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cagnot, Carole</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rossignol, Emilie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Danjou, Hélène</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Veislinger, Aurélie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Samuel, Didier</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Duclos-Vallée, Jean-Charles</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dumortier, Jérôme</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Masson</subfield><subfield code="a">Holmes, Jason ELSEVIER</subfield><subfield code="t">A 4.5 </subfield><subfield code="d">2018</subfield><subfield code="g">Amsterdam</subfield><subfield code="w">(DE-627)ELV000519456</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:46</subfield><subfield code="g">year:2022</subfield><subfield code="g">number:9</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.clinre.2022.102024</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">33.05</subfield><subfield code="j">Experimentalphysik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">33.07</subfield><subfield code="j">Spektroskopie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">33.40</subfield><subfield code="j">Kernphysik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">46</subfield><subfield code="j">2022</subfield><subfield code="e">9</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
| score |
7.4004145 |